Sirona Biochem Corp. has partnered with Ray Matthews & Associates Inc. (RM&A) to provide corporate development and strategic advisory consulting services.
 
“Ray Matthews and his team have a proven track record in supporting financing efforts for several biotechnology companies,” said Dr. Howard Verrico, president and chief executive officer of Sirona Biochem. “Ray Matthews and Associates joins Sirona Biochem at an exciting time with the company focused on partnering and commercialization. Our company will benefit from RM&A’s broad range of experience in strategic planning, corporate development, investor relations and operational consultation.”
 
“In our first fund (Advantage), some of our early success was due to holdings which had novel solutions addressing blockbuster markets. Sirona Biochem has a compound in development that has the potential to achieve substantial shareholder value. I am excited to be able to add value and help attract additional talent and networks to advance this program,” said Ray Matthews of RM&A.